
Castle Biosciences CSTL
€ 17.54
-0.88%
Quartalsbericht 2026-Q1
hinzugefügt 06.05.2026
Land |
|
IPO-Jahr |
2019 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBALSPB |
Anteile |
29 M |
Marktkapitalisierung |
$ 590 M |
EBITDA (LTM) |
$ -20.7 M |
P/E (LTM) |
-19.8 |
P/S (LTM) |
2.02 |
EPS (LTM) |
-1.25 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Fulgent Genetics
FLGT
|
$ 17.11 | -1.55 % | $ 517 M | Nasdaq Global Market | ||
|
Guardant Health
GH
|
$ 118.67 | 0.56 % | $ 14.9 B | Nasdaq Global Select Market,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 116.26 | -0.27 % | $ 9.59 B | Nasdaq Global Select Market,SPB | ||
|
Agilent Technologies
A
|
$ 114.91 | 0.1 % | $ 34.9 B | NYSE,SPB | ||
|
Illumina
ILMN
|
$ 144.97 | 0.1 % | $ 23.1 B | Nasdaq Global Select Market,SPB | ||
|
Celcuity
CELC
|
$ 140.27 | -1.59 % | $ 6.56 B | Nasdaq Global Select Market | ||
|
Co-Diagnostics
CODX
|
$ 3.77 | 1.62 % | $ 5.01 M | Nasdaq Capital Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 22.03 | 2.13 % | $ 1.17 B | Nasdaq Global Market,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Lantheus Holdings
LNTH
|
$ 93.98 | -0.52 % | $ 6.34 B | Nasdaq Global Select Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Interpace Biosciences
IDXG
|
$ 1.82 | 1.11 % | $ 8.05 M | Nasdaq Global Select Market | ||
|
Medpace Holdings
MEDP
|
$ 431.07 | 0.23 % | $ 12.4 B | Nasdaq Global Select Market,SPB | ||
|
Mettler-Toledo International
MTD
|
$ 1 101.7 | 1.02 % | $ 22.7 B | NYSE,SPB | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Personalis
PSNL
|
$ 8.64 | 4.73 % | $ 771 M | Nasdaq Global Select Market | ||
|
Charles River Laboratories International
CRL
|
$ 159.55 | 0.39 % | $ 7.91 B | NYSE,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
NeoGenomics
NEO
|
$ 9.25 | 1.54 % | $ 1.18 B | Nasdaq Global Select Market,SPB | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
National Research Corporation
NRC
|
$ 19.03 | -0.05 % | $ 426 M | Nasdaq Global Select Market | ||
|
Natera
NTRA
|
$ 205.51 | 0.89 % | $ 20.2 B | Nasdaq Global Select Market,SPB | ||
|
Myriad Genetics
MYGN
|
$ 3.84 | -1.79 % | $ 356 M | Nasdaq Global Select Market,SPB | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
Twist Bioscience Corporation
TWST
|
$ 61.01 | 3.7 % | $ 3.65 B | Nasdaq Global Select Market,SPB | ||
|
Koninklijke Philips N.V.
PHG
|
$ 27.1 | -0.15 % | $ 25.7 B | NYSE | ||
|
Senseonics Holdings
SENS
|
$ 6.37 | 3.33 % | $ 266 M | NYSE American | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | ||
|
Biomerica
BMRA
|
$ 2.4 | -1.64 % | $ 5.51 M | Nasdaq Capital Market | ||
|
Waters Corporation
WAT
|
$ 340.15 | -0.2 % | $ 20.3 B | NYSE,SPB | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 259.15 | 1.4 % | $ 21.6 B | NYSE,SPB | ||
|
Thermo Fisher Scientific
TMO
|
$ 446.46 | -0.65 % | $ 168 B | NYSE,SPB | ||
|
Exagen
XGN
|
$ 4.3 | 0.7 % | $ 92.7 M | Nasdaq Global Market | ||
|
Trinity Biotech plc
TRIB
|
$ 0.61 | -2.43 % | $ 219 M | Nasdaq Global Select Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Neogen Corporation
NEOG
|
$ 9.16 | 3.44 % | $ 1.99 B | Nasdaq Global Select Market,SPB |